Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities

ME Shaker, HAM Gomaa, MA Abdelgawad… - International …, 2023 - Elsevier
Inflammation has been convicted of causing and worsening many liver diseases like acute
liver failure, fibrosis, cirrhosis, fatty liver and liver cancer. Pattern recognition receptors …

[HTML][HTML] Autoimmune hepatitis: Towards a personalized treatment

A Costaguta, G Costaguta… - World Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Autoimmune hepatitis is an uncommon condition that affects both adults and children and is
characterized by chronic and recurrent inflammatory activity in the liver. This inflammation is …

Escin suppresses immune cell infiltration and selectively modulates Nrf2/HO-1, TNF-α/JNK, and IL-22/STAT3 signaling pathways in concanavalin A-induced …

M Elshal, SH Hazem - Inflammopharmacology, 2022 - Springer
The current study aims to investigate the possible protective effect of escin, the active
constituent of a natural mixture of triterpene saponin glycoside, against immune-mediated …

Janus kinase inhibitor Tofacitinib alleviated acute hepatitis induced by lipopolysaccharide/D-galactosamine in mice

X Zhang, L Lin, L Li, K Hu, R Shao, L Zhang… - Molecular Biology …, 2023 - Springer
Abstract Background: The Janus kinase (JAK) is a crucial intracellular signaling hub for
numerous cytokines, which is extensively involved in the activation of inflammatory cascade …